Thyrocare Technologies Limited (THYROCARE.BO)
INR 703.0
(-0.36%)
INR 703.0
(-0.36%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.59 Billion INR | -42.65% |
| 2022 | 2.78 Billion INR | 28.31% |
| 2021 | 2.17 Billion INR | 14.62% |
| 2020 | 1.89 Billion INR | 8.02% |
| 2019 | 1.75 Billion INR | 6.84% |
| 2018 | 1.64 Billion INR | 21.39% |
| 2017 | 1.35 Billion INR | 9.37% |
| 2016 | 1.23 Billion INR | 30.54% |
| 2015 | 947.96 Million INR | 50.16% |
| 2014 | 631.28 Million INR | 118.81% |
| 2013 | 288.49 Million INR | 99.89% |
| 2012 | 144.32 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 911.5 Million INR | 21.2% |
| 2024 Q1 | 400.9 Million INR | -15.24% |
| 2023 Q1 | 719.4 Million INR | -6.52% |
| 2023 Q4 | 473 Million INR | -39.51% |
| 2023 FY | 1.59 Billion INR | -42.65% |
| 2023 Q3 | 782 Million INR | 0.92% |
| 2023 Q2 | 774.9 Million INR | 7.71% |
| 2022 Q4 | 769.6 Million INR | 10.8% |
| 2022 Q1 | 609.8 Million INR | 0.38% |
| 2022 FY | 2.78 Billion INR | 28.31% |
| 2022 Q3 | 694.6 Million INR | -2.74% |
| 2022 Q2 | 714.2 Million INR | 17.12% |
| 2021 Q2 | 514.7 Million INR | 10.71% |
| 2021 Q3 | 594 Million INR | 15.41% |
| 2021 FY | 2.17 Billion INR | 14.62% |
| 2021 Q4 | 607.5 Million INR | 2.27% |
| 2021 Q1 | 464.9 Million INR | -20.98% |
| 2020 Q2 | 481.4 Million INR | 67.04% |
| 2020 FY | 1.89 Billion INR | 8.02% |
| 2020 Q4 | 588.3 Million INR | 9.37% |
| 2020 Q1 | 288.2 Million INR | -44.0% |
| 2020 Q3 | 537.9 Million INR | 11.74% |
| 2019 Q1 | 406.1 Million INR | -14.43% |
| 2019 Q2 | 411 Million INR | 1.21% |
| 2019 Q3 | 423.3 Million INR | 2.99% |
| 2019 Q4 | 514.6 Million INR | 21.57% |
| 2019 FY | 1.75 Billion INR | 6.84% |
| 2018 Q2 | 390.9 Million INR | 8.49% |
| 2018 FY | 1.64 Billion INR | 21.39% |
| 2018 Q4 | 474.6 Million INR | 13.79% |
| 2018 Q3 | 417.1 Million INR | 6.7% |
| 2018 Q1 | 360.3 Million INR | -7.76% |
| 2017 Q4 | 390.63 Million INR | 18.88% |
| 2017 Q2 | 313.7 Million INR | -6.13% |
| 2017 Q3 | 328.6 Million INR | 4.75% |
| 2017 Q1 | 334.2 Million INR | -9.14% |
| 2017 FY | 1.35 Billion INR | 9.37% |
| 2016 Q1 | 276.57 Million INR | 39.53% |
| 2016 FY | 1.23 Billion INR | 30.54% |
| 2016 Q2 | 277.34 Million INR | 0.28% |
| 2016 Q3 | 266.54 Million INR | -3.89% |
| 2016 Q4 | 367.82 Million INR | 38.0% |
| 2015 Q1 | 229.52 Million INR | 0.0% |
| 2015 Q2 | 193.62 Million INR | -15.64% |
| 2015 Q4 | 198.22 Million INR | -16.12% |
| 2015 Q3 | 236.3 Million INR | 22.04% |
| 2015 FY | 947.96 Million INR | 50.16% |
| 2014 FY | 631.28 Million INR | 118.81% |
| 2013 FY | 288.49 Million INR | 99.89% |
| 2012 FY | 144.32 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 1.57 Billion INR | -1.573% |
| Dr. Lal PathLabs Limited | 7.03 Billion INR | 77.288% |
| Metropolis Healthcare Limited | 3.3 Billion INR | 51.563% |
| Vijaya Diagnostic Centre Limited | 985.79 Million INR | -62.194% |
| Vimta Labs Limited | 450.67 Million INR | -254.783% |